NAI-603

N/A

Report date: 2024/12/13 13:18:29
NME

Base Information

Drug NameNAI-603
Drug Alias NameNAI-603
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVicuron Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVicuron Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A